3B Pharmaceuticals Competitors and Similar CompaniesClear all
3B Pharmaceuticals's competitors and similar companies include Abnova Corporation, Esperite and BioArctic.
 3B Pharmaceuticals 3B Pharmaceuticals (3BP) is a biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications. |  BioArctic BioArctic is a research-based biopharmaceutical company mainly focused on disease-modifying treatments and diagnostics for neurodegenerative diseases. | |||
Founding Date | Founding Date 2008 | Founding Date 2002 | Founding Date 2000 | Founding Date 2003 |
Type | Type Private | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations Berlin, DE HQ | Locations TW HQ Walnut, US | Locations Amsterdam, NL HQ Villeurbanne, FR | Locations Stockholm , SE HQ |
Employees | Employees 5510% increase | Employees 522% decrease | Employees 133 | Employees 107 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 38.3 m | Valuation ($) 1.3 b |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €11.8m (FY, 2018) | Revenue (est.) kr2b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods €4.3m (FY, 2018) | Cost of goods kr59.2m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit €7.5m (FY, 2018) | Gross profit kr1.9b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income (€18.5m) (FY, 2018) | Net income kr1b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Abnova Corporation
HQ
TW
Employees
52↓ 2% decrease
Abnova is a biotech company specializing in antibody and protein production.
View company
Esperite
HQ
Amsterdam, NL
Employees
133
Esperite is a company specializing in regenerative and predictive medicine.
View companyBioArctic
HQ
Stockholm , SE
Employees
107
BioArctic is a research-based biopharmaceutical company mainly focused on disease-modifying treatments and diagnostics for neurodegenerative diseases.
View company